Multiple Sclerosis

New Study Shows Promise In J&J’s Ponvory For MS

Johnson and Johnson’s new drug to treat multiple sclerosis, Ponvory, has performed well in a recent study compared to a similar MS drug. 

Multiple Sclerosis

Cognitive Rehabilitation Programs Effective In Treating MS-Related Cognitive Dysfunction

A new study has found that undergoing cognitive rehabilitation is effective at restoring cognition in individuals with MS.

Multiple Sclerosis

Study: Newly Diagnosed MS Shows Cluster of Symptoms

A new study published in the Multiple Sclerosis Journal has found that several common symptoms of MS often cluster together for patients in their first year following diagnosis

Multiple Sclerosis

MS Stem Cell Trial Receives FDA Authorization

The FDA recently approved a Phase II clinical trial which aims to treat MS patients using autologous adipose-derived mesenchymal stem cell infusions

Send this to a friend